Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lunai Bioworks
AddedFeb 20, 2024
UpdatedJul 4, 2026
Lunai Bioworks

Lunai Bioworks

LA-based Renovaro Biosciences develops advanced cell and gene therapies for cancer and infectious diseases.

HQ
Los Angeles, CA, US
Overview
Compare
Employees

Renovaro Biosciences, based in Los Angeles, develops advanced allogenic cell and gene therapies aimed at enhancing immune responses for long-term or life-long cancer remission and treating serious infectious diseases like HIV and Hepatitis B. The company focuses on innovative biotechnology solutions to address some of the most challenging health issues.

Renovaro Biosciences has made significant strides in the biotechnology sector, contributing to potential breakthroughs in cancer and infectious disease treatments. Their work has garnered attention for its potential to revolutionize medical treatments, positioning them as a key player in the biotech industry.

Lunai Bioworks - Similar Companies

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

RenBio logo

RenBio

renbio.com

Locanabio logo

Locanabio

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

Regennova logo

Regennova

regennova.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cellular Approaches logo

Cellular Approaches

Longeveron logo

Longeveron

longeveron.com

Novoron Bioscience logo

Novoron Bioscience

novoron.com

ElevateBio logo

ElevateBio

AlloCure logo

AlloCure

HebeCell logo

HebeCell

hebecellcorp.com

Platelet BioGenesis logo

Platelet BioGenesis

Renovar logo

Renovar

Regenxbio logo

Regenxbio

regenxbio.com

Lunai Bioworks - Quick Facts

Who are Lunai Bioworks' competitors?

Companies similar to Lunai Bioworks include Cellevolve Bio, RenBio, Locanabio and Rejuvenate Bio.

Where is Lunai Bioworks' headquarters located?

Lunai Bioworks' headquarters is located in Los Angeles, CA, US.

How many employees does Lunai Bioworks have?

Lunai Bioworks has 30 employees as of Feb 5, 2024.

Lunai Bioworks - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapies
  • Gene Therapies
Tags
  • Healthtech
Unique IDs
  • secCik: 0001527728
  • ticker: LNAI
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research